In the BioHarmony Drug Report Database

"Preview" Icon

Hydrocodone

Hysingla Er, Vantrela Er, Zohydro Er (hydrocodone) is a small molecule pharmaceutical. Hydrocodone was first approved as Hysingla Er on 2013-10-25. It is used to treat cough, obstructive lung diseases, and postoperative pain in the USA. The pharmaceutical is active against mu-type opioid receptor. In addition, it is known to target kappa-type opioid receptor. Hydrocodone bitartrate and homatropine methylbromide’s patents are valid until 2034-09-12 (FDA).

 

Trade Name

 

Hysingla Er, Vantrela Er, Zohydro Er
 

Common Name

 

hydrocodone
 

ChEMBL ID

 

CHEMBL1457
 

Indication

 

cough, obstructive lung diseases, postoperative pain
 

Drug Class

 

Image (chem structure or protein)

Hydrocodone structure rendering